Article

Misleading Lipids?

Fed Pract. 2005 October;22(10):46
PDF Download

 

Recommended Reading

Reducing Wait Times for Cardiac Consultation
Federal Practitioner
Comparing Effects of Daily and Twice Weekly Simvastatin
Federal Practitioner
Rosiglitazone to Prevent Restenosis
Federal Practitioner
Effects of Statins in Type 2 Diabetes
Federal Practitioner
Disparity Between CVD Risk and Mortality?
Federal Practitioner
Post-PCI Fluvastatin for Diabetics
Federal Practitioner
Thrombosis in Drug-Eluting Stents
Federal Practitioner
The Value of Pulse Pressure in Women
Federal Practitioner
Warfarin and Ethnicity
Federal Practitioner
Fibrates for MI Risk in Metabolic Syndrome
Federal Practitioner